Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/7878
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Genes Dev. 2016;30(5):489-501.
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the adipose tissue. This systemic syndrome, termed cancer-associated cachexia (CAC), is a major cause of morbidity and mortality. While once attributed solely to decreased food intake, the present description of cancer cachexia is a disorder of multiorgan energy imbalance. Here we review the molecules and pathways responsible for metabolic dysfunction in CAC and the ideas that led to the current understanding.
cancer-associated cachexia (CAC) | metabolic failure | skeletal muscle atrophy | white adipose tissue (WAT) browning
Adipose Tissue, White | Cachexia | Carbohydrate Metabolism | Endocrine System | Humans | Inflammation | Lipid Metabolism | Liver | Muscular Atrophy | Neoplasms
Files in this item
- Mechanismsofmetabolicdysfuncti ...